US court upholds patents on MS drug Copaxone
Posted: Mon Jun 25, 2012 11:46 pm
A federal court upheld Teva Pharmaceutical Industries Ltd.'s patents on its multiple-sclerosis drug Copaxone, helping the generic drug giant to beat back threats to its top-selling drug from rivals Mylan Inc. and Momenta Pharmaceuticals Inc.
The dispute put Teva--the world's biggest manufacturer of generic drugs--in the unusual position of defending against some of the same arguments it has made against other branded drugs in previous patent battles.
By seeking to cast Teva's claims to its branded drug as "invalid and unenforceable," rivals Mylan and Momenta employed a well-trodden tactic of Teva itself.
A U.S. district court in New York rejected those claims, however, ruling Friday that generic versions of Copaxone being separately developed by Mylan and Momenta infringe upon Teva's claims to the drug.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1903